Offsetting costs of new ablation technologies with increased procedural efficiency and volume
Leonard Ilkhanoff, Brett D. Atwater(Duke Medical Center), Keva Garg(Alaska Heart and Vascular Institute), Chirag Sandesara(Alaska Heart and Vascular Institute), Marc Wish, Adam S. Fein(Alaska Heart and Vascular Institute), Eunice Yang(Alaska Heart and Vascular Institute), Zachary Hollis(Inova Fairfax Hospital), Joseph C. Lee(Alaska Heart and Vascular Institute), Robert L. McSwain(Alaska Heart and Vascular Institute), Mohammad Ghazvini(Alaska Heart and Vascular Institute), Xitlalitc Plasters(Alaska Heart and Vascular Institute), David Laslett, Haroon Rashid(Alaska Heart and Vascular Institute), Vineet Kumar, Elizabeth Held, Aysha Arshad(Alaska Heart and Vascular Institute), Christopher M. O’Connor(Alaska Heart and Vascular Institute), Stephen A. Gaeta, Jae (Jeff) Lee(Alaska Heart and Vascular Institute), Mutaz Alkalbani(Alaska Heart and Vascular Institute)
Cited by 0
Related Papers
Medical large language models are vulnerable to data-poisoning attacks
|Nature Medicine|2025|171
Left Atrial LGE and Arrhythmia Recurrence Following Pulmonary Vein Isolation for Paroxysmal and Persistent AF
|JACC. Cardiovascular imaging|2016|118
Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking
|Radiology|2018|99
Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study
|European Heart Journal|2019|95
Urotensin II Promotes Hypertrophy of Cardiac Myocytes via Mitogen-Activated Protein Kinases
|Molecular Endocrinology|2004|89